We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Absology

ABSOLOGY is a medical equipment manufacturer that develops and mass-produces in vitro diagnostic medical devices. ABS... read more Featured Products: More products

Download Mobile App





Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes

By HospiMedica International staff writers
Posted on 16 Nov 2022
Print article
Image: The ABSOL POCT immunoassay system is on display at MEDICA 2022 (Photo courtesy of Absology)
Image: The ABSOL POCT immunoassay system is on display at MEDICA 2022 (Photo courtesy of Absology)

Absology Co., Ltd. (Gyeonggi-do, Korea) is participating in MEDICA 2022 where the company is exhibiting its POC FIA (Fluorescence Immunoassay) analyzer that uses microfluidic technology for the accurate quantitative diagnosis of concentration of biomarkers for a range of diseases.

At MEDICA 2022, Absology is showcasing its ABSOL POCT analyzer that uses FIA technology to quantitatively diagnose the concentration of biomarkers. It has a test time of only five minutes and features a vivid expressed GUI along with a convenient built-in printer. Alongside ABSOL, the company is showcasing the ABSOL HS high-sensitive ELISA analyzer for early disease screening. ABSOL HS can detect Femtogram level molecules using Absology’s proprietary PIFA (Photooxidation Induced Fluorescence Amplification) technology. It has a test time of only 30 minutes and requires just 20uL of blood sample. Compact and affordable, the portable and light weight ABSOL HS is a flexible platform for any kind of ELISA protocol. Absology offers a wide test menu for the ABSOL and ABSOL HS systems, including PSA, Testosterone, Vitamin D, TSH, FreeT4, Thyroid Combo, Cortisol, PCT, COVID-19 IgM/IgG, COVID-19 Ag, COVID-19 Neutralizing Antibody, and Influenza A/B.

Related Links:
Absology Co., Ltd. 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Vital Signs Monitor
Vista 120 SC
New
Parenteral Nutrition Solution
Olimel Portfolio

Print article

Channels

Critical Care

view channel
Image: The heart patch is produced from induced pluripotent stem cells derived heart muscle cells in a collagen hydrogel (Photo courtesy of UMG/Eva Meyer-Besting)

Heart Patch Offers Innovative Treatment Option for Advanced Heart Failure Patients

After successful preclinical testing in an animal model, the world’s first treatment involving heart tissue cultivated from stem cells has been administered to patients. This milestone is a significant... Read more

Surgical Techniques

view channel
Image: The groundbreaking tool can transform outcomes for stroke intervention (Photo courtesy of Shutterstock)

Groundbreaking Tool Accurately Predicts Stroke Outcome for Better Carotid Surgery Decisions

Stroke continues to be a significant global health concern, ranking as the second leading cause of mortality worldwide. Timely intervention is crucial for stroke patients, with carotid endarterectomy (CEA)... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.